News Briefs: CMS Rescinds Most Favored Nation Model | Jan. 13, 2022
-
CMS issued a final rule on Dec. 29 that rescinded the Most Favored Nation model. The mandatory model would have priced Medicare Part B drugs on the U.S. market based on their prices in certain countries. An interim final rule that was published in November 2020 had been blocked from being implemented on Jan. 1, 2021.
CMS published a proposed rule on Jan. 12 that would rein in direct and indirect remuneration (DIR) fees, which pharmacies have long complained about. The proposal would save consumers about $21.3 billion but cost the federal government $40.0 billion from 2023 through 2032.
Read more
The Latest
Meet Our Reporters
Meet Our Reporters
PREMIUM CONTENT AND PREMIUM INSIGHTS
To gain access to this article you need to have a Premium Subscription.
Click the link below to access today!
Already a subscriber? Click here to log in.
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.